Company Filing History:
1 out of 134 
1 out of 3,687 
1 out of 8 Years Active: 2024
Title: Lucia Jelinkova: Innovator in Malaria Immunology
Introduction: Lucia Jelinkova, an accomplished inventor based in Albuquerque, New Mexico, has made significant contributions to the field of immunology, particularly in the fight against malaria. With her innovative work, she has developed a patented immunogen that holds the potential for treating individuals at risk of this deadly disease.
Latest Patents: Lucia’s most notable patent is titled "Malaria immunogen and methods for using same." This patent describes an immunogen that comprises an immunogenic carrier and an antigenic malaria circumsporozoite protein (CSP) peptide. The specific peptide, NPDPNANPNVDPNAN (comprising amino acids 5-19 of SEQ ID NO:1), is intricately linked to the immunogenic carrier. The immunogen is designed to be administered to subjects who are either suffering from or at risk of malaria, showcasing its significant potential for medical applications.
Career Highlights: Throughout her career, Lucia has been associated with distinguished organizations, including UNM Rainforest Innovations and The Johns Hopkins University. Her work in these institutions has allowed her to blend academic theory with practical applications in the medical field, further establishing her as a leader in her specialty.
Collaborations: In her quest to advance her research and applications, Lucia has collaborated with notable scientists such as Bryce Chackerian and David S Peabody. These partnerships have enabled her to expand her research and validate her innovative approaches in malaria treatment.
Conclusion: Lucia Jelinkova stands as a beacon of innovation in the field of malaria treatment. Her unique immunogen not only exemplifies her ingenuity but also her commitment to addressing global health challenges. With her patent and collaborative efforts, she contributes significantly to advancements in immunology and the ongoing battle against malaria.